Merck to acquire Verona Pharma for $10 billion
09/07/2025 11:31
July 9 (Reuters) - Merck MRK.N will buy UK-based Verona Pharma VRNA.O for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's presence in respiratory treatments as it readies for the patent expiry of its blockbuster cancer drug. (Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj Kalluvila) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Verona Pharma
See all newsBrief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak